Kythera Biopharmaceuticals Appoints F. Michael Ball to Board of Directors

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CALABASAS, Calif., Sept. 19, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it has named F. Michael (Mike) Ball, Chief Executive Officer (CEO) of Hospira, Inc. (NYSE:HSP) to its Board of Directors.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC